{
  "DOI": "10.1038/s41431-021-00928-4",
  "ISSN": [
    "1018-4813",
    "1476-5438"
  ],
  "URL": "http://dx.doi.org/10.1038/s41431-021-00928-4",
  "alternative-id": [
    "928"
  ],
  "assertion": [
    {
      "group": {
        "label": "Article History",
        "name": "ArticleHistory"
      },
      "label": "Received",
      "name": "received",
      "order": 1,
      "value": "30 April 2021"
    },
    {
      "group": {
        "label": "Article History",
        "name": "ArticleHistory"
      },
      "label": "Revised",
      "name": "revised",
      "order": 2,
      "value": "6 June 2021"
    },
    {
      "group": {
        "label": "Article History",
        "name": "ArticleHistory"
      },
      "label": "Accepted",
      "name": "accepted",
      "order": 3,
      "value": "16 June 2021"
    },
    {
      "group": {
        "label": "Article History",
        "name": "ArticleHistory"
      },
      "label": "First Online",
      "name": "first_online",
      "order": 4,
      "value": "19 July 2021"
    },
    {
      "group": {
        "label": "Competing interests",
        "name": "EthicsHeading"
      },
      "name": "Ethics",
      "order": 1,
      "value": "YI is the founder of Oberon Sciences. The remaining authors have nothing to disclose."
    },
    {
      "group": {
        "label": "Ethical approval",
        "name": "EthicsHeading"
      },
      "name": "Ethics",
      "order": 2,
      "value": "Not applicable for this review."
    }
  ],
  "author": [
    {
      "affiliation": [],
      "family": "Hurvitz",
      "given": "Noa",
      "sequence": "first"
    },
    {
      "affiliation": [],
      "family": "Azmanov",
      "given": "Henny",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Kesler",
      "given": "Asa",
      "sequence": "additional"
    },
    {
      "ORCID": "http://orcid.org/0000-0003-0802-1220",
      "affiliation": [],
      "authenticated-orcid": false,
      "family": "Ilan",
      "given": "Yaron",
      "sequence": "additional"
    }
  ],
  "container-title": [
    "European Journal of Human Genetics"
  ],
  "content-domain": {
    "crossmark-restriction": false,
    "domain": [
      "link.springer.com"
    ]
  },
  "created": {
    "date-parts": [
      [
        2021,
        7,
        19
      ]
    ],
    "date-time": "2021-07-19T02:02:49Z",
    "timestamp": 1626660169000
  },
  "deposited": {
    "date-parts": [
      [
        2023,
        2,
        5
      ]
    ],
    "date-time": "2023-02-05T05:06:37Z",
    "timestamp": 1675573597000
  },
  "indexed": {
    "date-parts": [
      [
        2024,
        4,
        5
      ]
    ],
    "date-time": "2024-04-05T20:55:39Z",
    "timestamp": 1712350539413
  },
  "is-referenced-by-count": 41,
  "issn-type": [
    {
      "type": "print",
      "value": "1018-4813"
    },
    {
      "type": "electronic",
      "value": "1476-5438"
    }
  ],
  "issue": "10",
  "issued": {
    "date-parts": [
      [
        2021,
        7,
        19
      ]
    ]
  },
  "journal-issue": {
    "issue": "10",
    "published-print": {
      "date-parts": [
        [
          2021,
          10
        ]
      ]
    }
  },
  "language": "en",
  "license": [
    {
      "URL": "https://www.springernature.com/gp/researchers/text-and-data-mining",
      "content-version": "tdm",
      "delay-in-days": 0,
      "start": {
        "date-parts": [
          [
            2021,
            7,
            19
          ]
        ],
        "date-time": "2021-07-19T00:00:00Z",
        "timestamp": 1626652800000
      }
    },
    {
      "URL": "https://www.springernature.com/gp/researchers/text-and-data-mining",
      "content-version": "vor",
      "delay-in-days": 0,
      "start": {
        "date-parts": [
          [
            2021,
            7,
            19
          ]
        ],
        "date-time": "2021-07-19T00:00:00Z",
        "timestamp": 1626652800000
      }
    }
  ],
  "link": [
    {
      "URL": "https://www.nature.com/articles/s41431-021-00928-4.pdf",
      "content-type": "application/pdf",
      "content-version": "vor",
      "intended-application": "text-mining"
    },
    {
      "URL": "https://www.nature.com/articles/s41431-021-00928-4",
      "content-type": "text/html",
      "content-version": "vor",
      "intended-application": "text-mining"
    },
    {
      "URL": "https://www.nature.com/articles/s41431-021-00928-4.pdf",
      "content-type": "application/pdf",
      "content-version": "vor",
      "intended-application": "similarity-checking"
    }
  ],
  "member": "297",
  "page": "1485-1490",
  "prefix": "10.1038",
  "published": {
    "date-parts": [
      [
        2021,
        7,
        19
      ]
    ]
  },
  "published-online": {
    "date-parts": [
      [
        2021,
        7,
        19
      ]
    ]
  },
  "published-print": {
    "date-parts": [
      [
        2021,
        10
      ]
    ]
  },
  "publisher": "Springer Science and Business Media LLC",
  "reference": [
    {
      "key": "928_CR1",
      "unstructured": "Dementia—caring, ethics, ethnical and economical aspects: a systematic review. SBU System Rev. 2008."
    },
    {
      "DOI": "10.1186/s13023-020-01374-z",
      "author": "C Faviez",
      "doi-asserted-by": "publisher",
      "first-page": "1",
      "journal-title": "Orphanet J rare Dis",
      "key": "928_CR2",
      "unstructured": "Faviez C, Chen X, Garcelon N, Neuraz A, Knebelmann B, Salomon R, et al. Diagnosis support systems for rare diseases: a scoping review. Orphanet J rare Dis. 2020;15:1–16.",
      "volume": "15",
      "year": "2020"
    },
    {
      "DOI": "10.3390/diseases8040042",
      "doi-asserted-by": "crossref",
      "key": "928_CR3",
      "unstructured": "Villalon-Garcia I, Alvarez-Cordoba M, Suarez-Rivero JM, Povea-Cabello S, Talaveron-Rey M, Suarez-Carrillo A, et al. Precision medicine in rare diseases. Diseases. 2020;8."
    },
    {
      "DOI": "10.1186/s13023-020-01374-z",
      "author": "C Faviez",
      "doi-asserted-by": "publisher",
      "journal-title": "Orphanet J Rare Dis",
      "key": "928_CR4",
      "unstructured": "Faviez C, Chen X, Garcelon N, Neuraz A, Knebelmann B, Salomon R, et al. Diagnosis support systems for rare diseases: a scoping review. Orphanet J Rare Dis. 2020;15:94.",
      "volume": "15",
      "year": "2020"
    },
    {
      "DOI": "10.1016/j.isci.2020.101123",
      "author": "CE Lee",
      "doi-asserted-by": "publisher",
      "first-page": "101123",
      "journal-title": "iScience",
      "key": "928_CR5",
      "unstructured": "Lee CE, Singleton KS, Wallin M, Faundez V. Rare genetic diseases: nature’s experiments on human development. iScience. 2020;23:101123.",
      "volume": "23",
      "year": "2020"
    },
    {
      "DOI": "10.1002/ajmg.a.61124",
      "author": "CR Ferreira",
      "doi-asserted-by": "publisher",
      "first-page": "885",
      "journal-title": "Am J Med Genet A",
      "key": "928_CR6",
      "unstructured": "Ferreira CR. The burden of rare diseases. Am J Med Genet A. 2019;179:885–92.",
      "volume": "179",
      "year": "2019"
    },
    {
      "DOI": "10.1016/j.therap.2020.02.004",
      "author": "O Blin",
      "doi-asserted-by": "publisher",
      "first-page": "141",
      "journal-title": "Therapie",
      "key": "928_CR7",
      "unstructured": "Blin O, Lefebvre MN, Rascol O, Micallef J. Orphan drug clinical development. Therapie. 2020;75:141–7.",
      "volume": "75",
      "year": "2020"
    },
    {
      "DOI": "10.1038/s41573-019-0049-9",
      "author": "E Tambuyzer",
      "doi-asserted-by": "publisher",
      "first-page": "93",
      "journal-title": "Nat Rev Drug Discov",
      "key": "928_CR8",
      "unstructured": "Tambuyzer E, Vandendriessche B, Austin CP, Brooks PJ, Larsson K, Miller Needleman KI, et al. Therapies for rare diseases: therapeutic modalities, progress and challenges ahead. Nat Rev Drug Discov. 2020;19:93–111.",
      "volume": "19",
      "year": "2020"
    },
    {
      "DOI": "10.1038/s10038-019-0671-8",
      "author": "S Mitsuhashi",
      "doi-asserted-by": "publisher",
      "first-page": "11",
      "journal-title": "J Hum Genet",
      "key": "928_CR9",
      "unstructured": "Mitsuhashi S, Matsumoto N. Long-read sequencing for rare human genetic diseases. J Hum Genet. 2020;65:11–9.",
      "volume": "65",
      "year": "2020"
    },
    {
      "DOI": "10.1007/s11011-020-00617-z",
      "author": "K Pierzynowska",
      "doi-asserted-by": "publisher",
      "first-page": "1237",
      "journal-title": "Metab Brain Dis",
      "key": "928_CR10",
      "unstructured": "Pierzynowska K, Kaminska T, Wegrzyn G. One drug to treat many diseases: unlocking the economic trap of rare diseases. Metab Brain Dis. 2020;35:1237–40.",
      "volume": "35",
      "year": "2020"
    },
    {
      "DOI": "10.1186/s13023-020-01400-0",
      "author": "S Lanar",
      "doi-asserted-by": "publisher",
      "journal-title": "Orphanet J Rare Dis",
      "key": "928_CR11",
      "unstructured": "Lanar S, Acquadro C, Seaton J, Savre I, Arnould B. To what degree are orphan drugs patient-centered? A review of the current state of clinical research in rare diseases. Orphanet J Rare Dis. 2020;15:134.",
      "volume": "15",
      "year": "2020"
    },
    {
      "DOI": "10.1002/pds.4962",
      "author": "J Wu",
      "doi-asserted-by": "publisher",
      "first-page": "1213",
      "journal-title": "Pharmacoepidemiol Drug Saf",
      "key": "928_CR12",
      "unstructured": "Wu J, Wang C, Toh S, Pisa FE, Bauer L. Use of real-world evidence in regulatory decisions for rare diseases in the United States-current status and future directions. Pharmacoepidemiol Drug Saf. 2020;29:1213–8.",
      "volume": "29",
      "year": "2020"
    },
    {
      "DOI": "10.1002/humu.23056",
      "author": "M Horowitz",
      "doi-asserted-by": "publisher",
      "first-page": "1121",
      "journal-title": "Hum Mutat",
      "key": "928_CR13",
      "unstructured": "Horowitz M, Elstein D, Zimran A, Goker-Alpan O. New directions in gaucher disease. Hum Mutat. 2016;37:1121–36.",
      "volume": "37",
      "year": "2016"
    },
    {
      "author": "E Sidransky",
      "first-page": "273",
      "journal-title": "Disco Med",
      "key": "928_CR14",
      "unstructured": "Sidransky E. Gaucher disease: insights from a rare Mendelian disorder. Disco Med. 2012;14:273–81.",
      "volume": "14",
      "year": "2012"
    },
    {
      "author": "L Nalysnyk",
      "first-page": "1002",
      "journal-title": "J Manag Care Spec Pharm",
      "key": "928_CR15",
      "unstructured": "Nalysnyk L, Sugarman R, Cele C, Uyei J, Ward A. Budget impact analysis of eliglustat for the treatment of gaucher disease type 1 in the United States. J Manag Care Spec Pharm. 2018;24:1002–8.",
      "volume": "24",
      "year": "2018"
    },
    {
      "DOI": "10.1111/j.1365-2141.2012.09175.x",
      "author": "CE Hollak",
      "doi-asserted-by": "publisher",
      "first-page": "528",
      "journal-title": "Br J Haematol",
      "key": "928_CR16",
      "unstructured": "Hollak CE, Belmatoug N, Cole JA, Vom Dahl S, Deegan PB, Goldblatt J, et al. Characteristics of type I Gaucher disease associated with persistent thrombocytopenia after treatment with imiglucerase for 4–5 years. Br J Haematol. 2012;158:528–38.",
      "volume": "158",
      "year": "2012"
    },
    {
      "DOI": "10.1016/S0002-9343(02)01150-6",
      "author": "NJ Weinreb",
      "doi-asserted-by": "publisher",
      "first-page": "112",
      "journal-title": "Am J Med",
      "key": "928_CR17",
      "unstructured": "Weinreb NJ, Charrow J, Andersson HC, Kaplan P, Kolodny EH, Mistry P, et al. Effectiveness of enzyme replacement therapy in 1028 patients with type 1 Gaucher disease after 2 to 5 years of treatment: a report from the Gaucher Registry. Am J Med. 2002;113:112–9.",
      "volume": "113",
      "year": "2002"
    },
    {
      "DOI": "10.1177/0269215510382495",
      "author": "J Marsden",
      "doi-asserted-by": "publisher",
      "first-page": "195",
      "journal-title": "Clin Rehabil",
      "key": "928_CR18",
      "unstructured": "Marsden J, Harris C. Cerebellar ataxia: pathophysiology and rehabilitation. Clin Rehabil. 2011;25:195–216.",
      "volume": "25",
      "year": "2011"
    },
    {
      "DOI": "10.1002/mds.20375",
      "author": "BP van de Warrenburg",
      "doi-asserted-by": "publisher",
      "first-page": "497",
      "journal-title": "Mov Disord",
      "key": "928_CR19",
      "unstructured": "van de Warrenburg BP, Steijns JA, Munneke M, Kremer BP, Bloem BR. Falls in degenerative cerebellar ataxias. Mov Disord. 2005;20:497–500.",
      "volume": "20",
      "year": "2005"
    },
    {
      "DOI": "10.1016/0002-9343(94)90041-8",
      "author": "E Beutler",
      "doi-asserted-by": "publisher",
      "first-page": "1",
      "journal-title": "Am J Med",
      "key": "928_CR20",
      "unstructured": "Beutler E. Economic malpractice in the treatment of Gaucher’s disease. Am J Med. 1994;97:1–2.",
      "volume": "97",
      "year": "1994"
    },
    {
      "DOI": "10.1097/01.nrl.0000141651.35193.67",
      "author": "SL Perlman",
      "doi-asserted-by": "publisher",
      "first-page": "275",
      "journal-title": "Neurologist",
      "key": "928_CR21",
      "unstructured": "Perlman SL. Symptomatic and disease-modifying therapy for the progressive ataxias. Neurologist. 2004;10:275–89.",
      "volume": "10",
      "year": "2004"
    },
    {
      "DOI": "10.3389/fneur.2020.00711",
      "doi-asserted-by": "crossref",
      "key": "928_CR22",
      "unstructured": "Stanley WJ, Kelly CKL, Tung CC, Lok TW, Ringo TMK, Ho YK, et al. Cost of cerebellar ataxia in Hong Kong: a retrospective cost-of-illness analysis. Front Neurol. 2020;11."
    },
    {
      "DOI": "10.1002/mds.21798",
      "author": "J López-Bastida",
      "doi-asserted-by": "publisher",
      "first-page": "212",
      "journal-title": "Mov Disord",
      "key": "928_CR23",
      "unstructured": "López-Bastida J, Perestelo-Pérez L, Montón-álvarez F, Serrano-Aguilar P. Social economic costs and health-related quality of life in patients with degenerative cerebellar ataxia in Spain. Mov Disord. 2008;23:212–7.",
      "volume": "23",
      "year": "2008"
    },
    {
      "DOI": "10.4088/JCP.v69n1116",
      "author": "E van Duijn",
      "doi-asserted-by": "publisher",
      "first-page": "1804",
      "journal-title": "J Clin Psychiatry",
      "key": "928_CR24",
      "unstructured": "van Duijn E, Kingma EM, Timman R, Zitman FG, Tibben A, Roos RA, et al. Cross-sectional study on prevalences of psychiatric disorders in mutation carriers of Huntington’s disease compared with mutation-negative first-degree relatives. J Clin Psychiatry. 2008;69:1804–10.",
      "volume": "69",
      "year": "2008"
    },
    {
      "DOI": "10.1038/nrdp.2015.5",
      "author": "GP Bates",
      "doi-asserted-by": "publisher",
      "first-page": "15005",
      "journal-title": "Nat Rev Dis Prim",
      "key": "928_CR25",
      "unstructured": "Bates GP, Dorsey R, Gusella JF, Hayden MR, Kay C, Leavitt BR, et al. Huntington disease. Nat Rev Dis Prim. 2015;1:15005.",
      "volume": "1",
      "year": "2015"
    },
    {
      "author": "T Mestre",
      "first-page": "Cd006456",
      "journal-title": "Cochrane Database Syst Rev",
      "key": "928_CR26",
      "unstructured": "Mestre T, Ferreira J, Coelho MM, Rosa M, Sampaio C. Therapeutic interventions for symptomatic treatment in Huntington’s disease. Cochrane Database Syst Rev. 2009;3:Cd006456.",
      "volume": "3",
      "year": "2009"
    },
    {
      "DOI": "10.1001/jama.2016.8655",
      "author": "S Frank",
      "doi-asserted-by": "publisher",
      "first-page": "40",
      "journal-title": "JAMA",
      "key": "928_CR27",
      "unstructured": "Frank S, Testa CM, Stamler D, Kayson E, Davis C, Edmondson MC, et al. Effect of deutetrabenazine on chorea among patients with huntington disease: a randomized clinical trial. JAMA. 2016;316:40–50.",
      "volume": "316",
      "year": "2016"
    },
    {
      "DOI": "10.1016/S0140-6736(04)17551-X",
      "author": "VA Lennon",
      "doi-asserted-by": "publisher",
      "first-page": "2106",
      "journal-title": "Lancet",
      "key": "928_CR28",
      "unstructured": "Lennon VA, Wingerchuk DM, Kryzer TJ, Pittock SJ, Lucchinetti CF, Fujihara K, et al. A serum autoantibody marker of neuromyelitis optica: distinction from multiple sclerosis. Lancet. 2004;364:2106–12.",
      "volume": "364",
      "year": "2004"
    },
    {
      "author": "V Papp",
      "first-page": "59",
      "journal-title": "Neurology",
      "key": "928_CR29",
      "unstructured": "Papp V, Magyari M, Aktas O, Berger T, Broadley SA, Cabre P, et al. Worldwide incidence and prevalence of neuromyelitis optica: a systematic review. Neurology. 2021;96:59–77.",
      "volume": "96",
      "year": "2021"
    },
    {
      "DOI": "10.1212/WNL.0000000000001729",
      "author": "DM Wingerchuk",
      "doi-asserted-by": "publisher",
      "first-page": "177",
      "journal-title": "Neurology",
      "key": "928_CR30",
      "unstructured": "Wingerchuk DM, Banwell B, Bennett JL, Cabre P, Carroll W, Chitnis T, et al. International consensus diagnostic criteria for neuromyelitis optica spectrum disorders. Neurology. 2015;85:177–89.",
      "volume": "85",
      "year": "2015"
    },
    {
      "DOI": "10.1016/S1474-4422(07)70216-8",
      "author": "DM Wingerchuk",
      "doi-asserted-by": "publisher",
      "first-page": "805",
      "journal-title": "Lancet Neurol",
      "key": "928_CR31",
      "unstructured": "Wingerchuk DM, Lennon VA, Lucchinetti CF, Pittock SJ, Weinshenker BG. The spectrum of neuromyelitis optica. Lancet Neurol. 2007;6:805–15.",
      "volume": "6",
      "year": "2007"
    },
    {
      "DOI": "10.1111/j.1468-1331.2010.03066.x",
      "author": "J Sellner",
      "doi-asserted-by": "publisher",
      "first-page": "1019",
      "journal-title": "Eur J Neurol",
      "key": "928_CR32",
      "unstructured": "Sellner J, Boggild M, Clanet M, Hintzen RQ, Illes Z, Montalban X, et al. EFNS guidelines on diagnosis and management of neuromyelitis optica. Eur J Neurol. 2010;17:1019–32.",
      "volume": "17",
      "year": "2010"
    },
    {
      "DOI": "10.1016/j.msard.2019.05.013",
      "author": "K Holroyd",
      "doi-asserted-by": "publisher",
      "first-page": "44",
      "journal-title": "Mult Scler Relat Disord",
      "key": "928_CR33",
      "unstructured": "Holroyd K, Vogel A, Lynch K, Gazdag B, Voghel M, Alakel N, et al. Neuromyelitis optica testing and treatment: Availability and affordability in 60 countries. Mult Scler Relat Disord. 2019;33:44–50.",
      "volume": "33",
      "year": "2019"
    },
    {
      "DOI": "10.1002/acr.22289",
      "author": "MA Karsdal",
      "doi-asserted-by": "publisher",
      "first-page": "1273",
      "journal-title": "Arthritis Care Res",
      "key": "928_CR34",
      "unstructured": "Karsdal MA, Bay-Jensen AC, Henriksen K, Christiansen C, Genant HK, Chamberlain C, et al. Rheumatoid arthritis: a case for personalized health care? Arthritis Care Res. 2014;66:1273–80.",
      "volume": "66",
      "year": "2014"
    },
    {
      "DOI": "10.1016/j.metabol.2017.01.011",
      "author": "P Hamet",
      "doi-asserted-by": "publisher",
      "first-page": "S36",
      "journal-title": "Metabolism",
      "key": "928_CR35",
      "unstructured": "Hamet P, Tremblay J. Artificial intelligence in medicine. Metabolism. 2017;69:S36–S40.",
      "volume": "69",
      "year": "2017"
    },
    {
      "DOI": "10.1371/journal.pgen.1007341",
      "author": "DR Schrider",
      "doi-asserted-by": "publisher",
      "first-page": "e1007341",
      "journal-title": "PLOS Genet",
      "key": "928_CR36",
      "unstructured": "Schrider DR, Ayroles J, Matute DR, Kern AD. Supervised machine learning reveals introgressed loci in the genomes of Drosophila simulans and D. sechellia. PLOS Genet. 2018;14:e1007341.",
      "volume": "14",
      "year": "2018"
    },
    {
      "DOI": "10.3389/fdgth.2020.569178",
      "doi-asserted-by": "crossref",
      "key": "928_CR37",
      "unstructured": "Ilan Y. Second-generation digital health platforms: placing the patient at the center and focusing on clinically meaningful endpoints title: second-generation artificial intelligence algorithms. Front Dig Health. 2020."
    },
    {
      "key": "928_CR38",
      "unstructured": "Holzinger A, Biemann C, Constantinos, Douglas. What do we need to build explainable AI systems for the medical domain? arXiv pre-print server. 2017."
    },
    {
      "DOI": "10.3390/genes10120978",
      "doi-asserted-by": "crossref",
      "key": "928_CR39",
      "unstructured": "Brasil S, Pascoal C, Francisco R, Dos Reis Ferreira V, Videira PA, Valadao AG. Artificial Intelligence (AI) in Rare Diseases: Is the Future Brighter? Genes (Basel). 2019;10."
    },
    {
      "DOI": "10.1016/j.kint.2019.11.037",
      "author": "N Garcelon",
      "doi-asserted-by": "publisher",
      "first-page": "676",
      "journal-title": "Kidney Int",
      "key": "928_CR40",
      "unstructured": "Garcelon N, Burgun A, Salomon R, Neuraz A. Electronic health records for the diagnosis of rare diseases. Kidney Int. 2020;97:676–86.",
      "volume": "97",
      "year": "2020"
    },
    {
      "DOI": "10.1186/s13023-020-01536-z",
      "author": "J Schaaf",
      "doi-asserted-by": "publisher",
      "journal-title": "Orphanet J Rare Dis",
      "key": "928_CR41",
      "unstructured": "Schaaf J, Sedlmayr M, Schaefer J, Storf H. Diagnosis of Rare Diseases: a scoping review of clinical decision support systems. Orphanet J Rare Dis. 2020;15:263.",
      "volume": "15",
      "year": "2020"
    },
    {
      "DOI": "10.1186/s13023-020-01424-6",
      "author": "J Schaefer",
      "doi-asserted-by": "publisher",
      "journal-title": "Orphanet J Rare Dis",
      "key": "928_CR42",
      "unstructured": "Schaefer J, Lehne M, Schepers J, Prasser F, Thun S. The use of machine learning in rare diseases: a scoping review. Orphanet J Rare Dis. 2020;15:145.",
      "volume": "15",
      "year": "2020"
    },
    {
      "author": "RL Palmer",
      "first-page": "301",
      "journal-title": "Inf Sci",
      "key": "928_CR43",
      "unstructured": "Palmer RL, Helmholz P, Baynam G. Cliniface: phenotypic visualisation and analysis using non-rigid registration of 3d facial images. the international archives of photogrammetry, remote sensing and spatial. Inf Sci. 2020;43:301–8.",
      "volume": "43",
      "year": "2020"
    },
    {
      "DOI": "10.1186/s13023-015-0258-1",
      "author": "E Heslop",
      "doi-asserted-by": "publisher",
      "journal-title": "Orphanet J Rare Dis",
      "key": "928_CR44",
      "unstructured": "Heslop E, Csimma C, Straub V, McCall J, Nagaraju K, Wagner KR, et al. The TREAT-NMD advisory committee for therapeutics (TACT): an innovative de-risking model to foster orphan drug development. Orphanet J Rare Dis. 2015;10:49.",
      "volume": "10",
      "year": "2015"
    },
    {
      "key": "928_CR45",
      "unstructured": "Track.health. Measure mamypsjfstfAahthLaM."
    },
    {
      "DOI": "10.1016/j.jcf.2019.09.002",
      "author": "J Wood",
      "doi-asserted-by": "publisher",
      "first-page": "271",
      "journal-title": "J Cyst Fibros",
      "key": "928_CR46",
      "unstructured": "Wood J, Jenkins S, Putrino D, Mulrennan S, Morey S, Cecins N, et al. A smartphone application for reporting symptoms in adults with cystic fibrosis improves the detection of exacerbations: results of a randomised controlled trial. J Cyst Fibros. 2020;19:271–6.",
      "volume": "19",
      "year": "2020"
    },
    {
      "DOI": "10.1186/s12916-019-1426-2",
      "doi-asserted-by": "crossref",
      "key": "928_CR47",
      "unstructured": "Kelly CJ, Karthikesalingam A, Suleyman M, Corrado G, King D. Key challenges for delivering clinical impact with artificial intelligence. BMC Medicine. 2019;17."
    },
    {
      "DOI": "10.1038/s41746-018-0048-y",
      "doi-asserted-by": "crossref",
      "key": "928_CR48",
      "unstructured": "Keane PA, Topol EJ. With an eye to AI and autonomous diagnosis. Nature Publishing Group; 2018."
    },
    {
      "DOI": "10.1370/afm.1713",
      "author": "T Bodenheimer",
      "doi-asserted-by": "publisher",
      "first-page": "573",
      "journal-title": "Ann Fam Med",
      "key": "928_CR49",
      "unstructured": "Bodenheimer T, Sinsky C. From triple to quadruple aim: care of the patient requires care of the provider. Ann Fam Med. 2014;12:573–6.",
      "volume": "12",
      "year": "2014"
    },
    {
      "key": "928_CR50",
      "unstructured": "https://www.tmaprecisionhealth.com/. viewed 5 Apr 2021. 2021."
    },
    {
      "DOI": "10.1016/j.omtm.2020.06.006",
      "author": "Y Ilan",
      "doi-asserted-by": "publisher",
      "first-page": "335",
      "journal-title": "Mol Ther Methods Clin Dev",
      "key": "928_CR51",
      "unstructured": "Ilan Y. Overcoming compensatory mechanisms toward chronic drug administration to ensure long-term, sustainable beneficial effects. Mol Ther Methods Clin Dev. 2020;18:335–44.",
      "volume": "18",
      "year": "2020"
    },
    {
      "DOI": "10.1007/s12038-019-9958-3",
      "doi-asserted-by": "crossref",
      "key": "928_CR52",
      "unstructured": "Ilan Y. Overcoming randomness does not rule out the importance of inherent randomness for functionality. J Biosci. 2019;44."
    },
    {
      "DOI": "10.1093/rheumatology/key209",
      "author": "F Conti",
      "doi-asserted-by": "publisher",
      "first-page": "vii11",
      "journal-title": "Rheumatology",
      "key": "928_CR53",
      "unstructured": "Conti F, Atzeni F, Massaro L, Chiara Gerardi M, Gremese E, Passiu G, et al. The influence of comorbidities on the efficacy of tumour necrosis factor inhibitors, and the effect of tumour necrosis factor inhibitors on comorbidities in rheumatoid arthritis: report from a National Consensus Conference. Rheumatology 2018;57:vii11–vii22. (57 Suppl 7)",
      "volume": "57",
      "year": "2018"
    },
    {
      "DOI": "10.3390/ijerph18020811",
      "doi-asserted-by": "crossref",
      "key": "928_CR54",
      "unstructured": "Ilan Y. Improving global healthcare and reducing costs using second-generation artificial intelligence-based digital pills: a market disruptor. Int J Environ Res Public Health. 2021;18."
    },
    {
      "DOI": "10.1186/s12967-019-1798-2",
      "author": "Y Ilan",
      "doi-asserted-by": "publisher",
      "journal-title": "J Transl Med",
      "key": "928_CR55",
      "unstructured": "Ilan Y. Generating randomness: making the most out of disordering a false order into a real one. J Transl Med. 2019;17:49.",
      "volume": "17",
      "year": "2019"
    },
    {
      "DOI": "10.1023/A:1023306419861",
      "author": "M Kyriazis",
      "doi-asserted-by": "publisher",
      "first-page": "75",
      "journal-title": "Biogerontology",
      "key": "928_CR56",
      "unstructured": "Kyriazis M. Practical applications of chaos theory to the modulation of human ageing: nature prefers chaos to regularity. Biogerontology. 2003;4:75–90.",
      "volume": "4",
      "year": "2003"
    },
    {
      "DOI": "10.1212/WNL.30.12.1257",
      "author": "WJ Weiner",
      "doi-asserted-by": "publisher",
      "first-page": "1257",
      "journal-title": "Neurology",
      "key": "928_CR57",
      "unstructured": "Weiner WJ, Koller WC, Perlik S, Nausieda PA, Klawans HL. Drug holiday and management of Parkinson disease. Neurology. 1980;30:1257–61.",
      "volume": "30",
      "year": "1980"
    },
    {
      "DOI": "10.1016/j.ctarc.2020.100240",
      "author": "Y Ilan",
      "doi-asserted-by": "publisher",
      "first-page": "100240",
      "journal-title": "Cancer Treat Res Commun",
      "key": "928_CR58",
      "unstructured": "Ilan Y, Spigelman Z. Establishing patient-tailored variability-based paradigms for anti-cancer therapy: Using the inherent trajectories which underlie cancer for overcoming drug resistance. Cancer Treat Res Commun. 2020;25:100240.",
      "volume": "25",
      "year": "2020"
    },
    {
      "DOI": "10.3389/fphys.2019.01542",
      "author": "A Kenig",
      "doi-asserted-by": "publisher",
      "first-page": "1542",
      "journal-title": "Front Physiol",
      "key": "928_CR59",
      "unstructured": "Kenig A, Ilan Y. A personalized signature and chronotherapy-based platform for improving the efficacy of sepsis treatment. Front Physiol. 2019;10:1542.",
      "volume": "10",
      "year": "2019"
    },
    {
      "DOI": "10.1097/MPA.0000000000001626",
      "author": "A Kessler",
      "doi-asserted-by": "publisher",
      "first-page": "1024",
      "journal-title": "Pancreas",
      "key": "928_CR60",
      "unstructured": "Kessler A, Weksler-Zangen S, Ilan Y. Role of the immune system and the circadian rhythm in the pathogenesis of chronic pancreatitis: establishing a personalized signature for improving the effect of immunotherapies for chronic pancreatitis. Pancreas. 2020;49:1024–32.",
      "volume": "49",
      "year": "2020"
    },
    {
      "DOI": "10.3389/fimmu.2019.02726",
      "author": "T Khoury",
      "doi-asserted-by": "publisher",
      "first-page": "2726",
      "journal-title": "Front Immunol",
      "key": "928_CR61",
      "unstructured": "Khoury T, Ilan Y. Introducing patterns of variability for overcoming compensatory adaptation of the immune system to immunomodulatory agents: a novel method for improving clinical response to anti-TNF therapies. Front Immunol. 2019;10:2726.",
      "volume": "10",
      "year": "2019"
    },
    {
      "DOI": "10.1016/j.seizure.2020.06.032",
      "author": "A Potruch",
      "doi-asserted-by": "publisher",
      "first-page": "201",
      "journal-title": "Seizure",
      "key": "928_CR62",
      "unstructured": "Potruch A, Khoury ST, Ilan Y. The role of chronobiology in drug-resistance epilepsy: the potential use of a variability and chronotherapy-based individualized platform for improving the response to anti-seizure drugs. Seizure. 2020;80:201–11.",
      "volume": "80",
      "year": "2020"
    },
    {
      "DOI": "10.1111/obr.13108",
      "author": "Y Kolben",
      "doi-asserted-by": "publisher",
      "first-page": "e13108",
      "journal-title": "Obes Rev",
      "key": "928_CR63",
      "unstructured": "Kolben Y, Weksler-Zangen S, Ilan Y. Adropin as a potential mediator of the metabolic system-autonomic nervous system-chronobiology axis: implementing a personalized signature-based platform for chronotherapy. Obes Rev. 2021;22:e13108.",
      "volume": "22",
      "year": "2021"
    },
    {
      "DOI": "10.1016/j.orcp.2021.02.003",
      "author": "T Khoury",
      "doi-asserted-by": "publisher",
      "first-page": "114",
      "journal-title": "Obes Res Clin Pract",
      "key": "928_CR64",
      "unstructured": "Khoury T, Ilan Y. Platform introducing individually tailored variability in nerve stimulations and dietary regimen to prevent weight regain following weight loss in patients with obesity. Obes Res Clin Pract. 2021;15:114–23.",
      "volume": "15",
      "year": "2021"
    },
    {
      "DOI": "10.1080/22221751.2020.1776161",
      "author": "R Gelman",
      "doi-asserted-by": "publisher",
      "first-page": "1397",
      "journal-title": "Emerg Microbes Infect",
      "key": "928_CR65",
      "unstructured": "Gelman R, Bayatra A, Kessler A, Schwartz A, Ilan Y. Targeting SARS-CoV-2 receptors as a means for reducing infectivity and improving antiviral and immune response: an algorithm-based method for overcoming resistance to antiviral agents. Emerg Microbes Infect. 2020;9:1397–406.",
      "volume": "9",
      "year": "2020"
    },
    {
      "DOI": "10.1002/prp2.616",
      "author": "E Forkosh",
      "doi-asserted-by": "publisher",
      "first-page": "e00616",
      "journal-title": "Pharm Res Perspect",
      "key": "928_CR66",
      "unstructured": "Forkosh E, Kenig A, Ilan Y. Introducing variability in targeting the microtubules: review of current mechanisms and future directions in colchicine therapy. Pharm Res Perspect. 2020;8:e00616.",
      "volume": "8",
      "year": "2020"
    },
    {
      "DOI": "10.1002/jcp.27978",
      "author": "Y Ilan",
      "doi-asserted-by": "publisher",
      "first-page": "7923",
      "journal-title": "J Cell Physiol",
      "key": "928_CR67",
      "unstructured": "Ilan Y. Microtubules: from understanding their dynamics to using them as potential therapeutic targets. J Cell Physiol. 2019;234:7923–37.",
      "volume": "234",
      "year": "2019"
    },
    {
      "DOI": "10.1002/cbin.11157",
      "author": "Y Ilan",
      "doi-asserted-by": "publisher",
      "first-page": "739",
      "journal-title": "Cell Biol Int",
      "key": "928_CR68",
      "unstructured": "Ilan Y. Randomness in microtubule dynamics: an error that requires correction or an inherent plasticity required for normal cellular function? Cell Biol Int. 2019;43:739–48.",
      "volume": "43",
      "year": "2019"
    },
    {
      "DOI": "10.2147/CEG.S203823",
      "author": "Y Ilan",
      "doi-asserted-by": "publisher",
      "first-page": "209",
      "journal-title": "Clin Exp Gastroenterol",
      "key": "928_CR69",
      "unstructured": "Ilan Y. Why targeting the microbiome is not so successful: can randomness overcome the adaptation that occurs following gut manipulation? Clin Exp Gastroenterol. 2019;12:209–17.",
      "volume": "12",
      "year": "2019"
    },
    {
      "DOI": "10.3389/fimmu.2019.01143",
      "author": "Y Ilan",
      "doi-asserted-by": "publisher",
      "first-page": "1143",
      "journal-title": "Front Immunol",
      "key": "928_CR70",
      "unstructured": "Ilan Y. beta-Glycosphingolipids as mediators of both inflammation and immune tolerance: a manifestation of randomness in biological systems. Front Immunol. 2019;10:1143.",
      "volume": "10",
      "year": "2019"
    },
    {
      "author": "G Iskrov",
      "first-page": "270",
      "journal-title": "Ann Ist Super Sanita",
      "key": "928_CR71",
      "unstructured": "Iskrov G, Stefanov R, Ferrelli RM. Health systems for rare diseases: financial sustainability. Ann Ist Super Sanita. 2019;55:270–5.",
      "volume": "55",
      "year": "2019"
    }
  ],
  "reference-count": 71,
  "references-count": 71,
  "resource": {
    "primary": {
      "URL": "https://www.nature.com/articles/s41431-021-00928-4"
    }
  },
  "score": 0,
  "short-container-title": [
    "Eur J Hum Genet"
  ],
  "source": "Crossref",
  "title": [
    "Establishing a second-generation artificial intelligence-based system for improving diagnosis, treatment, and monitoring of patients with rare diseases"
  ],
  "type": "journal-article",
  "update-policy": "http://dx.doi.org/10.1007/springer_crossmark_policy",
  "volume": "29"
}